alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1229 Introduced in House (IH)]

<DOC>

118th CONGRESS
  1st Session
                                H. R. 1229

  To codify Executive Order 13950 (relating to combating race and sex 
                 stereotyping), and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 28, 2023

Mr. Bishop of North Carolina (for himself, Mr. Guest, Mr. Lamborn, Mr. 
  Buck, Mr. Perry, Mr. Ellzey, Mr. Joyce of Pennsylvania, Mr. Massie, 
Mrs. Lesko, Mr. Bost, Mr. Steube, Mrs. Miller of Illinois, Mr. Duncan, 
  Mr. Davidson, Mr. Burlison, Mrs. Boebert, Mr. Cline, Mr. Johnson of 
Louisiana, Mr. Good of Virginia, Mr. Rosendale, Mrs. Luna, Ms. Hageman, 
   Ms. Tenney, Mr. Brecheen, Mr. Ogles, Mr. McClintock, Mr. Roy, Mr. 
  Arrington, Mr. Carl, and Mr. Hudson) introduced the following bill; 
which was referred to the Committee on Education and the Workforce, and 
  in addition to the Committees on Oversight and Accountability, and 
   Armed Services, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL

 
  To codify Executive Order 13950 (relating to combating race and sex 
                 stereotyping), and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Stop CRT Act''.

SEC. 2. CODIFICATION OF EXECUTIVE ORDER.

    Executive Order 13950 (85 Fed. Reg. 60683; relating to combating 
race and sex stereotyping) shall have the force and effect of law.

SEC. 3. FEDERAL FUNDS LIMITATION.

    A Federal entity may not grant Federal funds to any entity that 
teaches or advances any of the following:
            (1) Any race is inherently superior or inferior to any 
        other race.
            (2) The United States is a fundamentally racist country.
            (3) The Declaration of Independence or the United States 
        Constitution are fundamentally racist documents.
            (4) An individual's moral worth is determined by his or her 
        race.
            (5) An individual, by virtue of his or her race, is 
        inherently racist or oppressive, whether consciously or 
        unconsciously.
            (6) An individual, because of his or her race, bears 
        responsibility for the actions committed by members of his or 
        her race.
                                 <all>
```
**EXHIBIT 23.1**

**Consent of Independent Registered Public Accounting Firm**

The Board of Directorsand Stockholders 

Harvard Bioscience, Inc. and subsidiaries: 

We consent to the incorporation by reference in Registration Statements Numbers 333-53848, 333-104544 and 333-135418 on Form S-8 of HarvardBioscience, Inc. and subsidiaries of our report dated March 11, 2008, with respect to the consolidated balance sheets of Harvard Bioscience, Inc. as of December 31, 2007 and 2006, and the related consolidated statements ofoperations, stockholders’ equity and comprehensive income (loss), and cash flows for each of the years in the three-year period ended December 31, 2007, and our report dated March 11, 2008 with respect to the effectiveness of internalcontrol over financial reporting as of December 31, 2007, which reports appear in the December 31, 2007 annual report on Form 10-K of Harvard Bioscience, Inc. 

Our reports include an explanatory paragraph regarding the adoption of the Statement of Financial Accounting Standards No. 123 (revised 2004),*Share-Based Payment*, effective January 1, 2006, Statement of Financial Accounting Standards, No. 158, *Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans-an amendment of FASB StatementsNo. 87, 88, 106 and 132(R)*, effective December 31, 2006, and the Company changed its method of quantifying errors in 2006. 

Our report dated March 11, 2008, on the effectiveness of internal control over financial reporting contains an explanatory paragraph that states that Harvard Bioscience, Inc. acquired Panlab s.l. (“Panlab”) during 2007, andmanagement excluded from its assessment of the effectiveness of Harvard Bioscience, Inc. and subsidiaries’ internal control over financial reporting as of December 31, 2007, Panlab’s internal control over financial reportingassociated with total assets of $11,895,236 and total revenues of $2,939,872 included in the consolidated financial statements of Harvard Bioscience, Inc. and subsidiaries’ as of and for the year ended December 31, 2007. Our audit ofinternal control over financial reporting of Harvard Bioscience, Inc. and subsidiaries also excluded an evaluation of the internal control over financial reporting of Panlab. 

Boston, Massachusetts 

March 11, 2008
EX-10.9



 Exhibit 10.9 

EMPLOYMENT AGREEMENT 

AMENDMENT NO. 1 
 This
Amendment No. 1 to Employment Agreement (this “Amendment”) is entered into as of June 5, 2017 by and between Adam K. Peterson (the “Executive”) and Boston Omaha Corporation, a Delaware corporation (the
“Company”). 
 The Company and the Executive are parties to an Employment Agreement dated August 1, 2015 (the
“Agreement”). 
 Now, therefore, in consideration of the premises and the mutual covenants herein contained and for other
good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
 1.
Amendment to Article II, Section 2.01(A) of the Agreement. The Company and the Executive agree that the Agreement is hereby amended by deleting all of Article II, Section 2.01(A), and inserting the following in its place: 

“The Executive will serve for a Base Salary equal to the federal minimum wage for the period through December 31, 2017 and shall not
be entitled to any Base Salary in excess of the federal minimum wage for any period prior to such date. Commencing January 1, 2018, the Executive will receive a Base Salary at the rate of $275,000 per annum, payable in accordance with the
Company’s payroll payment policy as in effect from time to time.” 
 2. No Other Amendment. Except as expressly amended
hereby, the Agreement shall remain unamended and in full force and effect. This Amendment is only effective in the specific instance and for the specific purpose for which it is given and shall not be effective for any other purpose, and shall not
be deemed to be a waiver of, amendment of, or consent to or modification of any other term or provision of the Agreement. 
 3. Governing
Law. This Amendment, the performance of this Amendment and any and all matters arising directly or indirectly herefrom shall be governed by and construed and enforced in accordance with the internal laws of the Commonwealth of Massachusetts,
without giving effect to the conflict or choice of law provisions and principles thereof. 
 4. Counterparts. This Amendment may be
executed in any number of counterparts including facsimile or PDF counterpart signature pages, each of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument. 

IN WITNESS WHEREOF, the Company and the Executive have duly executed this Amendment as of the date first written above. 

 

			
	BOSTON OMAHA CORPORATION
		
	By:	 	/s/ Alex B. Rozek
		 	 Name: Alex B. Rozek
 Title: Co-Chief
Executive Officer

	
	EXECUTIVE
		 	 /s/ Adam K. Peterson

		 	Adam K. Peterson
**Exhibit 31.2**

CERTIFICATION 

I, William R. Broaddrick, certifythat: 

1.              I have reviewed this Annual Report on Form 10-KSB of Arena Resources, Inc. 

2.              Based on my knowledge, this annual report does not contain any untrue statement          of a material fact or omit to state a material fact necessary to make the          statements made, in light of the circumstances under which such statements were          made, not misleading with respect to the period covered by this annual report; 

3.              Based on my knowledge, the financial statements, and other financial information          included in this annual report, fairly present in all material respects the          financial condition, results of operations and cash flows of the registrant as          of, and for, the periods presented in this annual report; 

4.              The registrant’s other certifying officer and I are responsible for          establishing and maintaining disclosure controls and procedures (as defined in          Exchange Act Rules 13a-15 and 15d-15(e)) for the registrant and have: 

a)              designed such disclosure controls and procedures, or caused such disclosure          controls and procedures to be designed under our supervision, to ensure that          material information relating to the registrant, including its consolidated          subsidiaries, is made known to us by others within those entities, particularly          during the period in which this annual report is being prepared; 

b)              evaluated the effectiveness of the registrant’s disclosure controls and          procedures and presented in this annual report our conclusions about the          effectiveness of the disclosure controls and procedures as of the end of the          period covered by this annual report (the “Evaluation Date”); and 

c)              disclosed in this report any change of the registrant’s internal control          over financial reporting that occurred during the registrant’s most recent          fiscal quarter (the registrant’s fourth quarter in the case of an annual          reporter) that has materially affected, or is reasonably likely to affect, the          registrant’s internal control over financial reporting. 

5.              The registrant’s other certifying officer and I have disclosed, based on          our most recent evaluation of internal control over financial reporting, to the          registrant’s auditors and the audit committee of registrant’s board of          directors (or persons performing the equivalent functions): 

a)              all significant deficiencies and material weaknesses in the design or operation          of internal control and financial reporting which are reasonably likely to          adversely affect the registrant’s ability to record, process, summarize and          report financial information; and 

b)              any fraud, whether or not material, that involves management or other employees          who have a significant role in the registrant’s internal control over          financial reporting. 

/s/ William R. Broaddrick
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED DECEMBER 1, 2022

NO. 03-21-00611-CV

Jose Pablo Cortina-Pineda, Appellant

v.

Courtney Cortina-Pineda, Appellee

APPEAL FROM THE 425TH JUDICIAL DISTRICT COURT OF WILLIAMSON COUNTY

BEFORE CHIEF JUSTICE BYRNE, JUSTICES KELLY AND SMITH

AFFIRMED -- OPINION BY JUSTICE KELLY

This is an appeal from the decree of divorce signed by the trial court on October 22, 2021.

Having reviewed the record and the parties’ arguments, the Court holds that there was no 

reversible error in the decree. Therefore, the Court affirms the trial court’s divorce decree.

Because appellant is indigent and unable to pay costs, no adjudication of costs is made.
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
No. 03-4357

UNITED STATES OF AMERICA, Plaintiff - Appellee,
versus
MICHAEL ALEXANDER, Defendant - Appellant.

Appeal from the United States District Court for the District of Maryland, at Greenbelt. Alexander Williams, Jr., District Judge. (CR-02-430) Submitted: February 2, 2004 Decided: February 17, 2004 Before NIEMEYER, WILLIAMS, and KING, Circuit Judges. Affirmed by unpublished per curiam opinion. James Wyda, Federal Public Defender, Denise C. Barrett, Assistant Federal Public Defender, Martin G. Bahl, Staff Attorney, OFFICE OF THE FEDERAL PUBLIC DEFENDER, Baltimore, Maryland, for Appellant. Thomas M. DiBiagio, United States Attorney, Bryan E. Foreman, Assistant United States Attorney, Greenbelt, Maryland, for Appellee. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).- 2 - PER CURIAM: Michael Alexander was convicted by a jury of one count of possession with intent to distribute crack cocaine and one count of possession with intent to distribute marijuana, and was sentenced to seventy months imprisonment. He appeals, claiming that the district court erred in admitting expert testimony from a law enforcement official that included an opinion as to Alexander’s intent, allegedly in violation of Fed. R. Evid. 704(b). Because he failed to object at trial, we review this claim only for plain error. Fed. R. Crim. P. 52(b). To establish plain error, Alexander must show: (1) there was an error; (2) the error was plain or clear under current law; (3) the error affected substantial rights so as to prejudice him; and (4) the error seriously affected the fairness, integrity, or public reputation of the judicial proceedings. United States v. Olano , 507 U.S. 725, 731-32 (1993). We find that there was no error. An expert witness may testify about an established practice among drug dealers, provided that he does not speak directly to the guilt or innocence of the accused. SeeUnited States v. Conyers , 118 F.3d 755, 758 (D.C. Cir. 1997). We find that the officer’s testimony here did not offer an opinion as to Alexander’s intent. He testified only that the evidence presented (quantity, packaging, and a digital scale) was inconsistent with personal use. Accordingly, we find no error in the district- 3 - court’s admission of the expert’s testimony. See United States v. Gastiaburo , 16 F.3d 582, 587-88 (4th Cir. 1994) (holding that admission of expert testimony that twenty-one “hits” of crack cocaine were “certainly possessed with the intent to distribute” was not plain error). Nor do we find that the expert’s testimony was unduly prejudicial under Fed. R. Evid. 403. Accordingly, we affirm Alexander’s conviction. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid in the decisional process. AFFIRMED
Exhibit
13.1
   CERTIFICATION BY
CEO AND CFO PURSUANT TO SECTION 906
  The certification
set forth below is being submitted in connection with Syngenta AG’s annual
report on Form 20-F (the “Report”) for the purpose of complying with Rule
13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the
“Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States
Code.
  Michael Mack, the
Chief Executive Officer and John Ramsay, the Chief Financial Officer of Syngenta
AG, each certifies that, to the best of his knowledge:
  1.
              the Report
      fully complies with the requirements of Section 13(a) or 15(d) of the
      Exchange Act; and
  2.
              the
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of Syngenta
      AG.
  February 18,
2010
  
  /s/ Michael
      MackName:
              Michael
      MackTitle:
              Chief
      Executive Officer
 
  
  /s/ John
      RamsayName:
              John
      RamsayTitle:
              Chief
      Financial Officer
Exhibit 32.1
 
 CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
 AS
ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 In
connection with the Annual Report of Java Detour, Inc. (the “Company”) on Form
10-K for the year ended December 31, 2009 as filed with the Securities and
Exchange Commission on the date hereof (the “Report”), the undersigned, Harry R.
Kraatz, Principal Executive Officer of the Company, certifies, pursuant to 18
U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002,
that:
 
 1.
              The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and
 
 2.
              The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.
 
 February
      5, 2010
              /s/
      Harry R. KraatzHarry R.
      Kraatz
                Chairman
      of the Board, and Chief Executive Officer
                (Principal
      Executive Officer)
 
 A signed
original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to Java Detour, Inc.. and will
be retained by Java Detour, Inc. and furnished to the Securities and Exchange
Commission or its staff upon request.
7.104 General procedures. ( a ) Acquisition planning should begin as soon as the agency need is identified, preferably well in advance of the fiscal year in which contract award or order placement is necessary. In developing the plan, the planner shall form a team consisting of all those who will be responsible for significant aspects of the acquisition, such as contracting, small business, fiscal, legal, and technical personnel. If contract performance is to be in a designated operational area or supporting a diplomatic or consular mission, the planner shall also consider inclusion of the combatant commander or chief of mission, as appropriate. The planner should review previous plans for similar acquisitions and discuss them with the key personnel involved in those acquisitions. At key dates specified in the plan or whenever significant changes occur, and no less often than annually, the planner shall review the plan and, if appropriate, revise it.
( b ) Requirements and logistics personnel should avoid issuing requirements on an urgent basis or with unrealistic delivery or performance schedules, since it generally restricts competition and increases prices. Early in the planning process, the planner should consult with requirements and logistics personnel who determine type, quality, quantity, and delivery requirements.
( c ) The planner shall coordinate with and secure the concurrence of the contracting officer in all acquisition planning. If the plan proposes using other than full and open competition when awarding a contract, the plan shall also be coordinated with the cognizant advocate for competition.
( d ) The planner shall coordinate the acquisition plan or strategy with the cognizant small business specialist when the strategy contemplates an acquisition meeting the thresholds in 7.107-4 for substantial bundling unless the contract or task order or delivery order is totally set-aside for small business under part 19. The small business specialist shall notify the agency Office of Small and Disadvantaged Business Utilization or the Office of Small Business Programs if the strategy involves— ( 1 ) Bundling that is unnecessary or unjustified; or
( 2 ) Bundled or consolidated requirements not identified as such by the agency (see 7.107).
( e ) The planner shall ensure that a COR is nominated as early as practicable in the acquisition process by the requirements official or in accordance with agency procedures. The contracting officer shall designate and authorize a COR as early as practicable after the nomination. See 1.602-2(d).
[48 FR 42124, Sept. 19, 1983, as amended at 50 FR 1735, Jan. 11, 1985; 50 FR 52433, Dec. 23, 1985; 67 FR 56118, Aug. 30, 2002; 68 FR 60005, Oct. 20, 2003; 71 FR 57366, Sept. 28, 2006; 73 FR 10956, Feb. 28, 2008; 75 FR 53132, Aug. 30, 2010; 76 FR 14546, Mar. 16, 2011; 77 FR 12926, Mar. 2, 2012; 78 FR 37676, June 21, 2013; 79 FR 24198, Apr. 29, 2014; 81 FR 67769, Sept. 30, 2016; 85 FR 11756, Feb. 27, 2020]
#### § 1005.40 Classes of utilization.

See § 1000.40.
#### § 1150.116 Nutrition education.

*Nutrition education* means those activities intended to broaden the understanding of sound nutritional principles, including the role of milk and dairy products in a balanced diet.
Featured Grant OpportunitySchool Emergency Response to Violence (Project SERV) (Funding Opportunity) 

Featured Grant OpportunityShare with Youth: NOAA Student Opportunities Database

Featured Grant OpportunityShort Courses in Social Determinants of Health for Research Education in Nursing Research (Funding...

Featured Grant OpportunityResearch on Law Enforcement Responses to Opioid Overdoses (Funding Opportunity)

Featured Grant OpportunityComprehensive Partnerships to Advance Cancer Health Equity (CPACHE) Program (Funding Opportunity)

Featured Grant OpportunityRisk and Protective Factors of Family Health and Family Level Interventions (Funding Opportunity)

Featured Grant OpportunityPersonnel Development to Improve Services and Results for Children with Disabilities--Doctoral...

Featured Grant OpportunityStanding Announcement for Tribal Title IV-E Plan Development Grants (Funding Opportunity)

Featured Grant OpportunityProviding Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and...

Featured Grant OpportunityFY 2024 Research on School-Based Hate Crimes (Funding Opportunity)

Featured Grant OpportunityChallenge America (Funding Opportunity)

Featured Grant OpportunityResearch and Evaluation on Firearm Violence and Mass Shootings (Funding Opportunity)

Featured Grant OpportunityNational Juvenile Court Data Archive (Funding Opportunity)

Featured Grant OpportunityGraduate Research Fellowship (Funding Opportunity)

Featured Grant OpportunityCommunity Programs for Outreach and Intervention with Youth and Young Adults at Clinical High Risk...

Featured Grant OpportunityPrint and Disseminate Child Victims and Witnesses Support Materials (Funding Opportunity)

# Growing Up Girl — A "Girls Matter!" Webinar

The first of three webinars in the "Girls Matter!" series provides an overview of the growth and development of adolescent girls. Key topics include biological, social, cultural, and societal factors that influence their maturation, impact of media on self-esteem, reproductive health, and teen dating violence. 

https://www.youtube.com/watch?v=reu1NT5_nOQ&utm_source=FindYouthInfo.gov&utm_medium=Federal%20Links&utm_content=%60&utm_campaign=Reports-and-Resources
EXHIBIT 32.2

CERTIFICATION OF CFO PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Community Financial Shares, Inc. (the Company) on Form 10-K for the period
ending December 31, 2006 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Eric J. Wedeen, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted
pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.



|                       
|-----------------------
|/s/ Eric J. Wedeen, CFO
|Eric J. Wedeen         
|Chief Financial Officer
|March 30, 2007         

* This certification shall not be deemed filed for purposes of Section 18 of the Securities and
Exchange Act of 1934, or the Exchange Act, or otherwise subject to the liability of Section 18 of the Exchange Act. Such certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the
Exchange Act, except to the extent that the Company specifically incorporates it by reference.
#### § 1215.5 Consumer information.

*Consumer information* means information and programs that will assist consumers and other persons in making evaluations and decisions regarding the purchasing, preparing, and use of popcorn.